apraga/org - Change QET6OJBIY5FL3PAXD3W7Z673IKDXTFODAX6UZ32TEJQESPK4RAFQC

Bisonex update

Created by Alexis Praga on October 8, 2023

QET6OJBIY5FL3PAXD3W7Z673IKDXTFODAX6UZ32TEJQESPK4RAFQC

Dependencies

In channels

main

Change contents

Insertion in workout.org at line 6696 [4.1]

[3.238]

* <2023-10-07 Sat> Workout
** RTO
- 33-15-15
** L-sit
- 0
** Muscle-up
- 3x1+2neg
** Extension:
-  3x22
** FL tucked row :
- 3x{3+2}
** Pistols :
- 3 (avec peu d'appui)
** Planche tucked push-up:
- 3x2 (travail forme)
** Compression:
- 3x10
** Norwegian roll
- 3x3 (en forçant)
* <2023-10-08 Sun> Running
medium 35min (+5marche dans les ronces)

Replacement in projects.org at line 88 [4.123895]

B:BD[5.568] → [6.51:66]

B:BD[6.66] → [2.15:1517]

∅:D[2.1517] → [6.3924:3941]

B:BD[6.3924] → [6.3924:3941]

*** TODO Cours
        - [1/5] <(Angines bacteriennes)>
        - [1/5] <(Antibiogramme - Enterobacteries)>
        - [1/5] <(Antibiogramme - Staphylocoques)>
        - [1/5] <(Antibiogramme - Streptococoque, enterocoque, Listeria)>
        - [1/5] <(Antibiogramme)>
        - [1/5] <(Cambylobacter)>
        - [1/5] <(Chlamydia - mycoplasmes)>
        - [1/5] <(Clostridium difficile)>
        - [1/5] <(Concentrations critiques)>
        - [1/5] <(Conseil anti-infectieux)>
        - [1/5] <(Declaration obligatoire)>
        - [1/5] <(Diagnostic moleculaire - Bacteriologie)>
        - [1/5] <(EBCU etiologies)>
        - [1/5] <(ECBU interpretation)>
        - [1/5] <(ECBU pre-analytique)>
        - [1/5] <(EEQ, CIQ)>
        - [1/5] <(Examen microscopique)>
        - [1/5] <(Gonocoque)>
        - [1/5] <(Hemocultures 1)>
        - [1/5] <(Hemocultures 2)>
        - [1/5] <(Hygiène)>
        - [1/5] <(Infections cutanees)>
        - [1/5] <(Legionelle)>
        - [1/5] <(MALDI - TOF)>
        - [1/5] <(Meningites bacteriennes )>
        - [1/5] <(Pre-analytique bacteriologie)>
        - [1/5] <(Qualité)>
        - [1/5] <(Salmonelle - shigelle)>
        - [1/5] <(Securite Transfusionnelle)>
        - [1/5] <(Serologie bacterienne)>
        - [1/5] <(Syphilis)>
        - [1/5] <(Tests rapides antigeniques et moleculaires)>
        - [1/5] <(Tuberculose)>
        - [1/5] <(Typage moleculaire bacterien)>
        - [1/5] <(Vaccination personnel)>
        - [1/5] <(Culture)>
  - [1/5] A. agalactiae
*** DONE Passe 1

[5.568]

[6.3941]

*** DONE Passe 1: tous [37/37]

Replacement in projects.org at line 90 [4.123895]

B:BD[6.4027] → [6.4027:4058]

*** TODO Passe 2: autres cours

[6.4027]

[6.4058]

  - [X] <(Angines bacteriennes)>
  - [X] <(Antibiogramme - Enterobacteries)>
  - [X] <(Antibiogramme - Staphylocoques)>
  - [X] <(Antibiogramme - Streptococoque, enterocoque, Listeria)>
  - [X] <(Antibiogramme)>
  - [X] <(Cambylobacter)>
  - [X] <(Chlamydia - mycoplasmes)>
  - [X] <(Clostridium difficile)>
  - [X] <(Concentrations critiques)>
  - [X] <(Conseil anti-infectieux)>
  - [X] <(Declaration obligatoire)>
  - [X] <(Diagnostic moleculaire - Bacteriologie)>
  - [X] <(EBCU etiologies)>
  - [X] <(ECBU interpretation)>
  - [X] <(ECBU pre-analytique)>
  - [X] <(EEQ, CIQ)>
  - [X] <(Examen microscopique)>
  - [X] <(Gonocoque)>
  - [X] <(Hemocultures 1)>
  - [X] <(Hemocultures 2)>
  - [X] <(Hygiène)>
  - [X] <(Infections cutanees)>
  - [X] <(Legionelle)>
  - [X] <(MALDI - TOF)>
  - [X] <(Meningites bacteriennes )>
  - [X] <(Pre-analytique bacteriologie)>
  - [X] <(Qualité)>
  - [X] <(Salmonelle - shigelle)>
  - [X] <(Securite Transfusionnelle)>
  - [X] <(Serologie bacterienne)>
  - [X] <(Syphilis)>
  - [X] <(Tests rapides antigeniques et moleculaires)>
  - [X] <(Tuberculose)>
  - [X] <(Typage moleculaire bacterien)>
  - [X] <(Vaccination personnel)>
  - [X] <(Culture)>
  - [X] A. agalactiae
*** TODO Passe 2: cours non tobmé avec interro + révision + interro [2/33]

Insertion in projects.org at line 129 [4.123895]

[6.4113]

  - [ ] <(Angines bacteriennes)>
  - [ ] <(Antibiogramme - Enterobacteries)>
  - [ ] <(Antibiogramme - Staphylocoques)>
  - [ ] <(Antibiogramme - Streptococoque, enterocoque, Listeria)>
  - [ ] <(Antibiogramme)>
  - [X] <(Cambylobacter)>
  - [ ] <(Chlamydia - mycoplasmes)>
  - [ ] <(Clostridium difficile)>
  - [ ] <(Concentrations critiques)>
  - [ ] <(Conseil anti-infectieux)>
  - [ ] <(Declaration obligatoire)>
  - [ ] <(Diagnostic moleculaire - Bacteriologie)>
  - [ ] <(EBCU etiologies)>
  - [ ] <(ECBU interpretation)>
  - [ ] <(ECBU pre-analytique)>
  - [ ] <(Examen microscopique)>
  - [ ] <(Gonocoque)>
  - [ ] <(Hemocultures 1)>
  - [ ] <(Hemocultures 2)>
  - [ ] <(Infections cutanees)>
  - [ ] <(Legionelle)>
  - [ ] <(MALDI - TOF)>
  - [ ] <(Meningites bacteriennes )>
  - [ ] <(Pre-analytique bacteriologie)>
  - [ ] BMR (cours ? définition a minima)
  - [ ] <(Qualité)>
  - [ ] <(Salmonelle - shigelle)>
  - [ ] <(Serologie bacterienne)>
  - [X] <(Syphilis)>
  - [ ] <(Tests rapides antigeniques et moleculaires)>
  - [ ] <(Tuberculose)>
  - [ ] <(Typage moleculaire bacterien)>
  - [ ] <(Culture)>
  - [ ] A. agalactiae

Replacement in projects.org at line 183 [4.123895]

B:BD[7.1550] → [7.1550:1622]

∅:D[7.1622] → [6.4518:4546]

B:BD[6.4518] → [6.4518:4546]

*** TODO [#A] Présenter Torres 2022 "~/papers/bacterio/torres2022.pdf"
SCHEDULED: <2023-10-07 Sat>

[7.1550]

[6.4546]

*** DONE [#A] Résumer Torres 2022
CLOSED: [2023-10-08 Sun 12:42] SCHEDULED: <2023-10-07 Sat>
<[Pdf]> - "~/papers/bacterio/torres2022.pdf"
<[Notes]> - "~/roam/research/biblio.org#** Multi-body-site colonization screening cultures for predicting multi-drug resistant Gram-negative and Gram-positive bacteremia in hematological patients"
*** TODO Première version avec contexte, Torres et nos résultats
SCHEDULED: <2023-10-08 Sun>
"~/roam/research/presentations/bacterio/depistage hemato/notes.org#* Présentation"

Replacement in projects.org at line 483 [4.123895]
B:BD[8.426] → [9.424:452]
```
SCHEDULED: <2023-10-08 Sun>
```
[8.426]
[8.454]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 485 [4.123895]
B:BD[8.489] → [10.7670:7698]
```
SCHEDULED: <2023-10-11 Wed>
```
[8.489]
[8.517]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 489 [4.123895]
B:BD[11.318] → [10.7699:7727]
```
SCHEDULED: <2023-10-11 Wed>
```
[11.318]
[11.407]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 491 [4.123895]
B:BD[11.475] → [10.7728:7756]
```
SCHEDULED: <2023-10-11 Wed>
```
[11.475]
[11.503]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 493 [4.123895]
B:BD[11.532] → [12.130:158]
```
SCHEDULED: <2023-10-08 Sun>
```
[11.532]
[9.453]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 495 [4.123895]
∅:D[9.480] → [12.159:187]
B:BD[8.702] → [12.159:187]
```
SCHEDULED: <2023-10-08 Sun>
```
[9.480]
[9.481]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 497 [4.123895]
B:BD[9.510] → [9.510:538]
```
SCHEDULED: <2023-10-10 Tue>
```
[9.510]
[11.560]
```
SCHEDULED: <2023-10-15 Sun>
```

Replacement in projects.org at line 817 [4.123895]

B:BD[6.4767] → [6.4767:4833]

*** TODO Changer phare arrière droit
SCHEDULED: <2023-10-08 Sun>

[6.4767]

[13.986]

*** DONE Changer phare arrière droit
CLOSED: [2023-10-08 Sun 13:24] SCHEDULED: <2023-10-08 Sun>
*** TODO Changer ampoule clignotant arrière droit
SCHEDULED: <2023-10-15 Sun>
Ampoule commandée

Replacement in projects.org at line 964 [4.123895]
B:BD[12.620] → [12.620:648]
```
SCHEDULED: <2023-10-08 Sun>
```
[12.620]
[12.648]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 970 [4.123895]
B:BD[12.730] → [12.730:758]
```
SCHEDULED: <2023-10-08 Sun>
```
[12.730]
[14.3077]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects.org at line 990 [4.123895]
B:BD[5.1128] → [6.5119:5147]
```
SCHEDULED: <2023-10-08 Sun>
```
[5.1128]
[5.1156]
```
SCHEDULED: <2023-10-15 Sun>
```
Replacement in projects/bisonex.org at line 76 [15.35]
B:BD[9.29646] → [7.2138:14708]
[9.29646]
Insertion in notes/medecine/20230528235406-antibiotiques.org at line 62 [17.138]
[16.1492]
[16.1492]
```
PéniM = oxacilline, cloxacilline
PéniA = amox
```

Replacement in notes/20230511172142-org_mode.org at line 14 [18.127]

B:BD[2.1919] → [2.1919:2109]

Lorsqu'on insère une citation, on peut créer une note (dans citar-notes-paths) pour cet article..
S'il y a un arsticle correspondant dans citar-library-paths, on peut également l'ouvrir.

[2.1919]

[2.2109]

Lorsqu'on insère une citation, on peut créer une note (dans citar-notes-paths) pour cet article avec "entrée"
S'il y a un asticle correspondant dans citar-library-paths, on peut également l'ouvrir.
Exemple
#+begin_src org
\* Research1
- [cite:@saffari2001] Best review
- [cite:@adang200] First review
#+end_src

Insertion in notes/20230511172142-org_mode.org at line 24 [18.127]
[2.2110]
[2.2110]

Bisonex update

Dependencies

In channels

Change contents

Insertion in workout.org at line 6696 [4.1]

Replacement in projects.org at line 88 [4.123895]

Replacement in projects.org at line 90 [4.123895]

Insertion in projects.org at line 129 [4.123895]

Replacement in projects.org at line 183 [4.123895]

Replacement in projects.org at line 483 [4.123895]

Replacement in projects.org at line 485 [4.123895]

Replacement in projects.org at line 489 [4.123895]

Replacement in projects.org at line 491 [4.123895]

Replacement in projects.org at line 493 [4.123895]

Replacement in projects.org at line 495 [4.123895]

Replacement in projects.org at line 497 [4.123895]

Replacement in projects.org at line 817 [4.123895]

Replacement in projects.org at line 964 [4.123895]

Replacement in projects.org at line 970 [4.123895]

Replacement in projects.org at line 990 [4.123895]

Replacement in projects/bisonex.org at line 76 [15.35]

Insertion in notes/medecine/20230528235406-antibiotiques.org at line 62 [17.138]

Replacement in notes/20230511172142-org_mode.org at line 14 [18.127]

Insertion in notes/20230511172142-org_mode.org at line 24 [18.127]